Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 139 of the 141 references it cites were found in a registry or an index.

Contemporary medical, device, and surgical therapies for obesity in adults

Abstract

The goal of obesity management is to improve health. Sustained weight loss of more than 10% overall bodyweight improves many of the complications associated with obesity (eg, prevention and control of type 2 diabetes, hypertension, fatty liver disease, and obstructive sleep apnoea), as well as quality of life. Maintenance of weight loss is the major challenge of obesity management. Like all chronic diseases, managing obesity requires a long-term, multimodal approach, taking into account each individual's treatment goals, and the benefit and risk of different therapies. In conjunction with lifestyle interventions, anti-obesity medications and bariatric surgery improve the maintenance of weight loss and associated health gains. Most available anti-obesity medications act on central appetite pathways to reduce hunger and food reward. In the past 5 years, therapeutic advances have seen the development of targeted treatments for monogenic obesities and a new generation of anti-obesity medications. These highly effective anti-obesity medications are associated with weight losses of more than 10% of overall bodyweight in more than two-thirds of clinical trial participants. Long-term data on safety, efficacy, and cardiovascular outcomes are awaited. Long-term studies have shown that bariatric surgical procedures typically lead to a durable weight loss of 25% and rapid, sustained improvements in complications of obesity, although they have not yet been compared with new-generation hig…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(22)02403-5

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 141 references

Research works printed but not linked: 1

  1. Lim, 2021, Lipodistrophy: a paradigm for understanding the consequences of “overloading” adipose tissue, Physiol Rev, 101, 907

Cited by

See all 738

Metadata

Authors
Perdomo, C. M., Cohen, R. V., Sumithran, P., Clément, K., & Frühbeck, G.
Affiliations
  • Instituto de Salud Carlos III (ES)
  • Hospital Alemão Oswaldo Cruz (BR)
  • The University of Melbourne (AU)
  • Inserm (FR)
Corresponding author
Frühbeck, Gema
Venue
The Lancet
Publisher
Elsevier BV
Published
2023-04
Volume
401
Issue
10382
Pages
1116-1130
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4319661516
Cited by
738
References
141
Citations by year
2026: 182 · 2025: 279 · 2024: 215 · 2023: 61
FWCI
26.56
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • Deposito Adademico Digital Universidad De Navarra (University of Navarra) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
obesity treatment, anti-obesity drugs, bariatric surgery, weight loss maintenance, lifestyle intervention, monogenic obesity, type 2 diabetes, hypertension, hepatic steatosis, obstructive sleep apnea, endoscopic obesity treatment, cardiovascular outcomes
MeSH terms
Adult, Body Weight, Diabetes Mellitus, Type 2, Humans, Obesity, Quality of Life, Weight Loss, Anti-Obesity Agents, Bariatric Surgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Contemporary medical, device, and surgical therapies for obesity in adults. https://app.cochat.ai/papers/10.1016/s0140-6736(22)02403-5
The paper
Perdomo, C. M., Cohen, R. V., Sumithran, P., Clément, K., & Frühbeck, G. (2023). Contemporary medical, device, and surgical therapies for obesity in adults. The Lancet. https://doi.org/10.1016/s0140-6736(22)02403-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.